Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Canary Capital's Injective ETF Filing Could Transform INJ Prices and Market Access
In a significant regulatory move, asset manager Canary Capital has formally filed with the U.S. Securities and Exchange Commission to launch a staked Injective exchange-traded fund. This development opens a critical window for institutional investors seeking regulated exposure to INJ token prices, while the crypto community watches whether this approval could reverse the token’s recent market weakness. The filing represents one of several crypto ETF applications the SEC is reviewing, but the combination of regulatory clarity and an expanding Injective ecosystem could create meaningful upside for the asset.
Technical Snapshot: Where INJ Prices Stand Today
At the time of the latest market update, INJ is trading at $3.03, down 1.46% over the past 24 hours. The month-to-date performance shows a more significant decline of 17.09%, indicating persistent selling pressure despite the positive catalysts building in the background. On the daily chart, INJ remains below its 50-day, 100-day, and 200-day moving averages—a bearish signal that suggests short-term momentum remains fragile. The Relative Strength Index (RSI) at current levels hints at potential oversold conditions, which historically precedes technical bounces.
For traders analyzing entry points, support clusters emerge around the $2.90-3.00 zone. If buyers defend this level and volume picks up, a recovery target toward $3.50-3.75 becomes plausible. However, a sustained rally requires increased trading activity and a catalyst that brings fresh capital into the ecosystem.
Ecosystem Growth Fuels ETF Momentum
Beyond the price action, the Injective platform itself is experiencing dramatic momentum. Transaction activity across the network has surged dramatically—from weekly counts in the 0-1,000 range in 2023 to nearly approaching 1 million transactions per week today. This exponential growth reflects expanded usage across decentralized exchanges, derivatives, staking, NFT interactions, and other on-chain operations.
The ecosystem is also positioned at the forefront of real-world asset (RWA) tokenization. In December 2025, Injective leadership discussed the on-chain integration of a $10 billion mortgage portfolio through their network, signaling how the protocol is expanding beyond purely crypto-native use cases. These developments create a stronger fundamental backdrop that could eventually influence INJ prices as institutional adoption accelerates.
SEC Filing Details: What Investors Should Know
The Canary proposal outlines a comprehensive ETF structure designed to scale institutional participation. If approved, the Canary Staked Injective ETF would list on Cboe, offering spot price exposure to INJ while allowing shareholders to earn staking rewards—a dual benefit not available through standard spot holdings.
The fund architecture incorporates institutional-grade custody safeguards. U.S. Bancorp Fund Services will manage transfer agent and cash custodian operations, while BitGo Trust Company handles digital asset safekeeping. The ETF will track performance via the INJ-USD reference rate index, with share creation and redemption occurring in 10,000-share blocks. Paralel Distributors LLC will handle marketing and distribution. These operational details underscore how the fund is engineered for scalability and regulatory compliance.
The Path Forward for INJ Recovery
The convergence of three factors could reshape INJ prices in coming months: regulatory approval of the Canary ETF, continued ecosystem expansion, and technical consolidation near current levels. ETF approvals historically catalyze inflows by reducing friction for institutional allocators, while the Injective platform’s real-world use cases attract a different class of builder and investor.
Whether INJ prices recover from here depends partly on whether the SEC greenlights the Canary application and market volume rebounds. Traders should monitor key resistance near $3.75 and $4.00, as a break above these levels would signal a more sustained recovery cycle for the token.